learn SCUBE3
a signaling molecule from dermal papilla cells being actively researched
Search
forLearn
5 / 801 resultslearn Microneedling
technique to create small wounds in skin to activate collagen production and hair growth
learn Mesotherapy
technique to inject very small amounts of beneficial chemicals into the scalp
learn Scalp Micropigmentation
scalp tattoos to mimic the appearance of light stubble
learn Transcutol P
Research
5 / 1000+ results
research Subcision: A Further Modification, an Ever Continuing Process
New subcision technique with a bent needle and syringe improves ease, effectiveness, and comfort for treating acne scars.
research Optimizing Post‐Acne Scar Treatment: A Pilot Comparative Study of Endo‐Radiofrequency Subcision With and Without Platelet‐Rich Plasma
Combining Endo-RF with PRP may improve acne scars better than Endo-RF alone.
research Subcision with Blunt Cannula in Combination with Injection of PRP and Microneedling in Treatment of Acne Scar
Combining subcision, PRP, and microneedling effectively treats acne scars with minimal side effects.
research 54481 A Comparative Analysis of CO2 Laser Therapy, RF Microneedling, TCA Cross, and Subcision on Post-Acne Boxcar Scarring in Skin of Color
Subcision is the most efficient, cost-effective, and safest treatment for post-acne boxcar scarring in skin of color.
research Combination treatment for acne scars Subcision with blunt cannula, platelet-rich plasma injections, and microneedling
The combination treatment improved acne scars.
Community Join
5 / 1000+ resultscommunity Cassiopea Announces FDA Submission of New Drug Application for Clascoterone Cream 1%, the First New Mechanism of Action for Acne in Nearly 40 Years
The conversation is about a new acne treatment cream called Clascoterone Cream 1%, which is the first new mechanism of action for acne in nearly 40 years. One person joked about hoping their face will be as clean as their bald head after using the cream.
community Following the recent IPO and the positive Phase 3 clinical data for VDPHL01 (extended-release oral minoxidil), what is the projected timeline for the FDA submission and the subsequent commercial availability on the market?
Veradermics' extended-release oral minoxidil is expected to be commercially available in 2027-2028, while another company, Minx, may release a similar product sooner. VDPHL01 is considered more clinically validated compared to Minx.
community Breezula 6 Month Topline Phase III Results Released
Breezula shows promising hair growth results, with up to 539% increase in hair count compared to placebo, and regulatory submissions are planned in the US and EU. Users are cautiously optimistic, noting the potential for Breezula to replace finasteride by targeting DHT without systemic effects.
community Clascoterone phase 3 results are out!
Clascoterone phase 3 results show promising improvements in hair count, but concerns about high costs and lack of detailed data remain. Users compare it to existing treatments like Minoxidil and Finasteride, expressing skepticism about its accessibility and effectiveness.
community Starting position, 21M (more in description)
A 21-year-old male discusses his starting position with hair loss. He mentions using Minoxidil, finasteride, and RU58841 as treatments.